| scholarly article | Q13442814 |
| P2093 | author name string | Jong-Hoon Kim | |
| P2860 | cites work | Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 |
| Ginseng pharmacology: multiple constituents and multiple actions | Q28138460 | ||
| Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action | Q28569709 | ||
| Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation. | Q29347020 | ||
| Application of atmospheric pressure chemical ionisation mass spectrometry in the identification and differentiation of Panax species. | Q33437112 | ||
| A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases | Q34424842 | ||
| Isolation and analysis of ginseng: advances and challenges | Q34667126 | ||
| Panax ginseng pharmacology: a nitric oxide link? | Q34742901 | ||
| Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, korean red ginseng: specifically, its anti-stress action for prevention of disease | Q35816253 | ||
| Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. | Q35847595 | ||
| Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action | Q36016935 | ||
| Systematic review of the effects of ginseng on cardiovascular risk factors | Q36333139 | ||
| Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction | Q36716408 | ||
| Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes | Q36844635 | ||
| Korean red ginseng inhibits arginase and contributes to endotheliumdependent vasorelaxation through endothelial nitric oxide synthase coupling | Q36861288 | ||
| Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser(157) phosphorylation on thrombin-induced platelet aggregation | Q36861329 | ||
| Ginsenosides: are any of them candidates for drugs acting on the central nervous system? | Q37031566 | ||
| Cardioprotective potential of Korean Red Ginseng extract on isoproterenol-induced cardiac injury in rats | Q37283782 | ||
| Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach | Q37283786 | ||
| A comparison of antioxidant activity of Korean White and Red Ginsengs on H2O2-induced oxidative stress in HepG2 hepatoma cells | Q37303193 | ||
| Inhibition of Arterial Myogenic Responses by a Mixed Aqueous Extract of Salvia Miltiorrhiza and Panax Notoginseng (PASEL) Showing Antihypertensive Effects | Q37398396 | ||
| An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes. | Q37576766 | ||
| Anti-hypoxic effect of ginsenoside Rbl on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo | Q39010661 | ||
| Ginsenoside-Rd, a purified component from panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice | Q39625234 | ||
| The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through PI3K/Akt and nitric oxide pathways | Q40078895 | ||
| Cardiovascular protection by ginsenosides and their nitric oxide releasing action | Q41183404 | ||
| Nitric oxide-dependent modulation of the delayed rectifier K+ current and the L-type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes | Q41973156 | ||
| Making a case for quantitative assessment of cardiovascular risk | Q42752792 | ||
| Total ginsenosides increase coronary perfusion flow in isolated rat hearts through activation of PI3K/Akt-eNOS signaling | Q42932047 | ||
| Ginsenoside Rb3 inhibits angiotensin II-induced vascular smooth muscle cells proliferation | Q42956312 | ||
| Vascular smooth muscle dysfunction and remodeling induced by ginsenoside Rg3, a bioactive component of ginseng | Q42965463 | ||
| Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats | Q43089682 | ||
| Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit | Q43095418 | ||
| The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart | Q43114540 | ||
| Effects of Korean red ginseng (Panax ginseng C.A. Mayer) and its isolated ginsenosides and polysaccharides on arterial stiffness in healthy individuals | Q43172307 | ||
| Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement | Q43242457 | ||
| Superoxide dismutase 10 years later: a drug in search of a use. | Q43845096 | ||
| Electrophysiological effects of ginseng and ginsenoside Re in guinea pig ventricular myocytes | Q44582035 | ||
| Prevention of ginsenoside-induced desensitization of Ca2+-activated Cl- current by microinjection of inositol hexakisphosphate in Xenopus laevis oocytes: involvement of GRK2 and beta-arrestin I. | Q44709082 | ||
| Modulating angiogenesis: the yin and the yang in ginseng | Q45037076 | ||
| Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress | Q45230170 | ||
| Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries | Q45244983 | ||
| Mutations Leu427, Asn428, and Leu431 residues within transmembrane domain-I-segment 6 attenuate ginsenoside-mediated L-type Ca(2+) channel current inhibitions. | Q45943178 | ||
| Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. | Q45967691 | ||
| Improving effect of post-treatment with Panax notoginseng saponins on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. | Q46231141 | ||
| Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP. | Q46289411 | ||
| Modulating effect of ginseng saponins on heterologously expressed HERG currents in Xenopus oocytes | Q46447472 | ||
| Relaxation of canine corporal smooth muscle relaxation by ginsenoside saponin Rg3 is independent from eNOS activation | Q46452292 | ||
| Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats. | Q46453049 | ||
| Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries | Q46484646 | ||
| Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits | Q46618939 | ||
| Panax ginseng reduces adriamycin-induced heart failure in rats | Q46863970 | ||
| Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. | Q46872976 | ||
| Antioxidant effects of ginsenoside Re in cardiomyocytes. | Q46959893 | ||
| Effects of ginsenosides and their metabolites on voltage-dependent Ca(2+) channel subtypes. | Q46971409 | ||
| Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells | Q48147335 | ||
| Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway | Q48473872 | ||
| Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. | Q48730502 | ||
| Effect of Korean red ginseng on arterial stiffness in subjects with hypertension. | Q50548689 | ||
| Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. | Q50569523 | ||
| Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells. | Q50677677 | ||
| Antithrombotic and antiplatelet activities of Korean red ginseng extract. | Q50704668 | ||
| Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression. | Q53375844 | ||
| Effects of extracts from Panax notoginseng and Panax ginseng fruit on vascular endothelial cell proliferation and migration in vitro. | Q53470490 | ||
| Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro. | Q53526848 | ||
| Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. | Q53676429 | ||
| Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism. | Q54605051 | ||
| Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats | Q54630124 | ||
| Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase. | Q54667707 | ||
| Panax ginseng Administration in the Rat Prevents Myocardial Ischemia-Reperfusion Damage Induced by Hyperbaric Oxygen: Evidence for an Antioxidant Intervention | Q59195748 | ||
| Ginsenoside Re, a Main Phytosterol of Panax ginseng, Activates Cardiac Potassium Channels via a Nongenomic Pathway of Sex Hormones | Q59767172 | ||
| The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis | Q71605264 | ||
| Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation | Q71749370 | ||
| Effect of ginsenoside Re on the electrophysiological activity of the heart | Q72511443 | ||
| Improved isolated heart contractility and mitochondrial oxidation after chronic treatment with Panax ginseng in rats | Q72582460 | ||
| Steaming of ginseng at high temperature enhances biological activity | Q73352506 | ||
| Liquid chromatographic determination of less polar ginsenosides in processed ginseng | Q74261693 | ||
| Ginsenoside Rf2, a new dammarane glycoside from Korean red ginseng (Panax ginseng) | Q77754108 | ||
| 116 cases of coronary angina pectoris treated with powder composed of radix ginseng, radix notoginseng and succinum | Q78098194 | ||
| Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor | Q79464774 | ||
| Shenfu injection suppresses apoptosis by regulation of Bcl-2 and caspase-3 during hypoxia/reoxygenation in neonatal rat cardiomyocytes in vitro | Q80122629 | ||
| Inhibitory effect of ginsenoside Rb1 on calcineurin signal pathway in cardiomyocyte hypertrophy induced by prostaglandin F2alpha | Q80640140 | ||
| Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques | Q81746585 | ||
| Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells | Q83333509 | ||
| Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway | Q83455115 | ||
| Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion | Q84504080 | ||
| Saponins of red ginseng. | Q115949427 | ||
| P433 | issue | 3 | |
| P921 | main subject | Panax ginseng | Q182881 |
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 264-269 | |
| P577 | publication date | 2017-10-21 | |
| P1433 | published in | Journal of Ginseng Research | Q26841821 |
| P1476 | title | Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. | |
| P478 | volume | 42 |
| Q89867799 | Anti-platelet role of Korean ginseng and ginsenosides in cardiovascular diseases |
| Q98613063 | Aquaporin 7 involved in GINSENOSIDE-RB1-mediated anti-obesity via peroxisome proliferator-activated receptor gamma pathway |
| Q91596534 | Combination of the ginsenosides Rb3 and Rb2 exerts protective effects against myocardial ischemia reperfusion injury in rats |
| Q58745615 | Developments in Taste-Masking Techniques for Traditional Chinese Medicines |
| Q64093688 | Efficacy and Mechanism of Panax Ginseng in Experimental Stroke |
| Q64086698 | Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis |
| Q91972929 | Ginsenoside-Rb1 for Ischemic Stroke: A Systematic Review and Meta-analysis of Preclinical Evidence and Possible Mechanisms |
| Q89522192 | Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling |
| Q94560412 | Ginsenosides: potential therapeutic source for fibrosis-associated human diseases |
| Q93095211 | Integrated metabolomics signature for assessing the longevity of Panax ginseng seeds |
| Q57817582 | Multifunctional Actions of Ninjinyoeito, a Japanese Kampo Medicine: Accumulated Scientific Evidence Based on Experiments With Cells and Animal Models, and Clinical Studies |
| Q90732395 | Panax Notoginseng Saponins Protect Cardiac Myocytes Against Endoplasmic Reticulum Stress and Associated Apoptosis Through Mediation of Intracellular Calcium Homeostasis |
| Q92855536 | Phenolic Compounds and Ginsenosides in Ginseng Shoots and Their Antioxidant and Anti-Inflammatory Capacities in LPS-Induced RAW264.7 Mouse Macrophages |
| Q64103615 | Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy |
| Q90397394 | Pro-Resolving Effect of Ginsenosides as an Anti-Inflammatory Mechanism of Panax ginseng |
| Q89804399 | Red Ginseng Improves Exercise Endurance by Promoting Mitochondrial Biogenesis and Myoblast Differentiation |
| Q90599824 | Rumex acetosa modulates platelet function and inhibits thrombus formation in rats |
| Q57214573 | Seasonal Variation and Possible Biosynthetic Pathway of Ginsenosides in Korean Ginseng Meyer |
| Q91723084 | Selection and validation of reference genes desirable for gene expression analysis by qRT-PCR in MeJA-treated ginseng hairy roots |
Search more.